… Using a SARS-CoV-2 Omicron monkey challenge … ), confers complete prophylactic or
therapeutic protection. Although we could select for SARS-CoV-2 mutants escaping neutralization …

… mAbs might target epitopes with less evolutionary selection pressure to mutate in SARS-CoV-2
variants compared with neutralizing mAbs; they can be Fc engineered … Show full caption …

… , Omicron variants readily cause infections in individuals who have been either previously
infected with other SARS-CoV-2 variants or subjected to full … , conferred complete prophylactic …

… library of patient-derived antiviral antibodies (21), we identified three monoclonal antibodies
(… 1C), the standalone IMM20184 antibody did not reach a complete neutralization of Omicron …

… Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers
full … to prevent infection with SARS-CoV-2 (BQ.1.1 variant) following inoculation therefore it …

… Omicron variant spike protein thus appear to confer broad … (B) Antibody binding footprints
for the monoclonal antibodies … IS and ACM provided the vaccine-induced patient-derived sera …

… The BQ and XBB subvariants of SARS-CoV-2 Omicron are now rapidly expanding, possibly
… Monoclonal antibodies capable of neutralizing the original Omicron variant were largely …

… , Delta and Omicron variants conferred strong resistance to our … In these studies, patient-derived
S2E12 and vaccine-induced … of recombinant monoclonal antibodies for the SARS-CoV-2 …

… conferred by circulating SARS-CoV-2 Omicron variants. The … In these studies, patient-derived
S2E12 and vaccine-induced … of recombinant monoclonal antibodies for the SARS-CoV-2 …

… This approach circumvents the need for patient-derived neutralizing antibodies, and may …
binding activity and neutralizing activity against the Omicron BA.1 variant, we attempted to …